Analyst
Klendas
Equibles does not estimate personal net worth.
Sandeep Kumar S. is recorded as Analyst at Klendas. Sandeep Kumar S. has spoken on 1 earnings call across 1 company, most recently for Alkem Laboratories Limited on August 14, 2026. The companies whose calls Sandeep Kumar S. spoke on are classified in the Healthcare sector.
“So, the first question is on like, what is the current status of denosomal biosimilar in the U.S.?”
Klendas
Analyst
Transcript header (unverified)
Alkem Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
“Alkem Laboratories Limited Q1 FY27 Earnings Conference Call”
Alkem Laboratories Limited
